Skip to content

FDM PHARMA

Active Private limited companyfounded 2014active for 12 yearsRue Wattelar Maximilien 68, 6040 CharleroiKBO/BCE: BE 0546.573.521

Timeline

27 events since 2014

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed NBBabbreviated format · on the deadline day
2025
Highest result from 2014 to 2025 net €357,146 ▲15.7% The operating result of €577,910 and the net result of €357,146 are both a record.
Liquidity more than doubled current ratio 5.03 The current ratio rises from 1.86 to 5.03. Short-term debt falls from €936,873 to €322,116.
Annual accounts 2024 filed PDFfull format · 4 days late
2024
Registered in the Peppol Directory Reachable for e-invoices through 0208:0546573521
Annual accounts 2023 filed PDFfull format · 30 days late
2023
Equity above €1m equity €1.2m ▲30.7% With a profit in every financial year since 2014, equity grows to €1.2m.
Annual accounts 2022 filed PDFfull format · 30 days late
2022
Annual accounts 2021 filed PDFfull format · 31 days late
2021
Annual accounts 2020 filed PDFmicro format · 27 days late
Merger: takes over Dissolution of the company · Company renamed to FDM PHARMA · Dissolved without liquidation · General meeting of 21-01-202111 points ▸
  • General meeting of 21-01-2021
  • is a shareholder
  • Incorporation, 11-02-2014
  • Merger by absorption
  • The operation takes effect in the accounts on 01-01-2021
  • The company holds all the shares of
  • Name change, FDM PHARMA
  • resigns as manager
  • appointed as director, not named in the articles
  • The registered office is at rue Maximilien Wattelar 68, 6040 Jumet (Charleroi)
  • Power of attorney granted to
  • The deed holds 17 more points.

Open the deed in the Belgian Official Gazette

Merger: FDM PHARMA takes over FDM PHARMA PDF
2020
Equity above €500,000 equity €539,452 ▲27.4% With a profit in every financial year since 2014, equity grows to €539,452.
Demerger proposal: FDM Pharma splits off to The company holds all the shares of FDM Pharma2 points ▸
  • Merger by absorption
  • The company holds all the shares of FDM Pharma
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2019 filed PDFmicro format · 11 days late
2019
Liquidity more than doubled current ratio 1.24 The current ratio rises from 0.60 to 1.24. Short-term debt falls from €59,123 to €58,770.
Annual accounts 2018 filed PDFmicro format · 29 days before the deadline
2018
Annual accounts 2017 filed PDFmicro format · 50 days before the deadline
2017
Equity above €200,000 equity €261,761 ▲66.9% With a profit in every financial year since 2014, equity grows to €261,761.
Annual accounts 2016 filed PDFmicro format · 47 days before the deadline
2016
Equity above €150,000 equity €156,795 ▲76.5% With a profit in every financial year since 2014, equity grows to €156,795.
Annual accounts 2015 filed PDFfull format · 45 days before the deadline
2015
Annual accounts 2014 filed PDFfull format · 38 days before the deadline
acts as permanent representativePartner: (mandate holder) · General meeting of 12-03-20153 points ▸
  • General meeting of 12-03-2015
  • acts as permanent representative
  • Partner, (mandate holder)

Open the deed in the Belgian Official Gazette

Registered office moved from Les Bons Villers to JumetThe registered office moved from rue de Fleurus 93, 6211 Les Bons Villers to rue Maximilien Wattelar 68, 6040 Jumet · “La centralisation, la prestation et la coordination de toutes activités de services financiers, d'assurances…” (deed in French) · General meeting of 12-03-20155 points ▸
  • General meeting of 12-03-2015
  • Incorporation, 11-02-2014
  • The registered office moved to rue Maximilien Wattelar 68, 6040 Jumet
  • Net-asset statement, 31-12-2014
  • Purpose change, “La centralisation, la prestation et la coordination de toutes activités de services financiers, d'assurances, juridiques, administratives et commerciales” (deed in French)
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

2014
First establishment At the time the registered office was still in Les Bons Villers.
IncorporationFounding capital of €18,600, 100 shares, €12,400 paid up · Founded by (partner) · appointed as manager · published on 25-02-20143 points ▸
  • Founded by (partner)
  • The founding capital is €18,600, divided into 100 shares
  • appointed as manager
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 14 February 2014, FDM PHARMA was incorporated by one private individual, with a starting capital of €18,600.12 In 2015 the registered office moved to Jumet.3 FDM PHARMA was merged into the company in 2021.4 has served as director since 2021.5 Total assets went from €2.0m in 2021 to €2.8m in 2025 and headcount from 1.6 to 3 full-time equivalents.6

  1. 1KBO register
  2. 2Belgian Official Gazette, 25-02-2014
  3. 3Belgian Official Gazette, 31-03-2015
  4. 4Belgian Official Gazette, 09-02-2021
  5. 5National Bank, annual accounts 2025
  6. 6National Bank, annual accounts 2021 and 2025

Mentions of companies taken over

FDM PHARMA, the company FDM PHARMA took over in the merger published in the Belgian Official Gazette on 09-02-2021, is named in 7 deeds.
Show the 7 deeds
PHARMACIE BOUILLON, the company FDM PHARMA took over in the merger published in the Belgian Official Gazette on 19-08-2011, is named in 3 deeds.
Show the 3 deeds

Next steps